SCHEMBL626767

SCHEMBL626767

C=CCC1=CC=CC[CH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18870061 0.70
SCHEMBL1651237 0.70
SCHEMBL7990529 0.70
SCHEMBL10491542 0.67
SCHEMBL8861633 0.67 CA12 (0.31)
SCHEMBL1917355 0.67
SCHEMBL8704203 0.67
SCHEMBL4964109 0.67
SCHEMBL2153677 0.67
SCHEMBL5592627 0.65 MAPT (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1664010-A1 SULFONAMIDES ANTAGONISING N-TYPE CALCIUM CHANNELS Vernalis (R&D) Limited (GB) 2006-06-07 EP claimed
EP-1558245-A2 USE OF GLYCOGEN PHOSPHORYLASE INHIBITORS FOR TREATMENT OF CARDIOVASCULAR DISEASES NOVO NORDISK A/S (DK) 2005-08-03 EP claimed
WO-2005068448-A1 SULFONAMIDES ANTAGONISING N-TYPE CALCIUM CHANNELS IONIX PHARMACEUTICALS LIMITED (GB) 2005-07-28 WO claimed
WO-2004037233-A2 USE OF GLYCOGEN PHOSPHORYLASE INHIBITORS FOR TREATMENT OF CARDIOVASCULAR DISEASES NOVO NORDISK A/S (DK) 2004-05-06 WO claimed
EP-1014785-A1 USE OF POLYMERS CONTAINING $g(b)-HYDROXYALKYLVINYLAMINE UNITS AS BIOCIDES BASF AKTIENGESELLSCHAFT (DE) 2000-07-05 EP claimed
WO-1999012418-A1 USE OF POLYMERS CONTAINING β-HYDROXYALKYLVINYLAMINE UNITS AS BIOCIDES BASF AKTIENGESELLSCHAFT (DE) 1999-03-18 WO claimed
US-20230348438-A1 PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2023-11-02 US disclosed
US-20200317644-A1 PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC (JP) 2020-10-08 US disclosed
EP-3524599-A1 PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF Japan Tobacco Inc. (JP) 2019-08-14 EP disclosed
US-20180346449-A1 PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC (JP) 2018-12-06 US disclosed
EP-3199533-A1 PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF Japan Tobacco Inc. (JP) 2017-08-02 EP disclosed
US-20150183763-A1 PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC (JP) 2015-07-02 US disclosed
CN-103917535-B Pyrazole compounds and pharmaceutical use thereof JAPAN TOBACCO INC 2015-06-24 CN disclosed
WO-1997049768-A1 CROSS-LINKED SILICONE BASED MATERIAL COMPRISING A BOUND PHOTOINITIATOR, ITS METHOD OF PREPARATION, HYDROPHILIC POLYMERIC PRODUCT OBTAINED FROM THIS MATERIAL AND ITS METHOD OF PREPARATION, AND NOVEL PHOTOINITIATORS ESSILOR INTERNATIONAL - COMPAGNIE GENERALE D'OPTIQUE (FR) 1997-12-31 WO disclosed
US-5620676-A ADENOSINE TRIPHOSPHATE DERIVATIVES; TREATMENT OF SEPTIC SHOCK OR BRAIN SEIZURES, LEARNING ENHANCEMENT THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1997-04-15 US disclosed
WO-1996019479-A1 MUSCARINIC RECEPTOR LIGANDS ALLELIX BIOPHARMACEUTICALS INC. (US) 1996-06-27 WO disclosed
EP-0419488-A4 LUBRICATING OIL COMPOSITIONS AND FUEL COMPOSITIONS CONTAINING SUBSTANTIALLY STRAIGHT CHAIN PINWHEEL ALKYLPHENYL POLY(OXYPROPYLENE) AMINOCARBAMATES CHEVRON RES (US) 1994-11-23 EP disclosed
US-5322529-A Liquid additive; internal combustion engines CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) 1994-06-21 US disclosed
EP-0419488-A1 LUBRICATING OIL COMPOSITIONS AND FUEL COMPOSITIONS CONTAINING SUBSTANTIALLY STRAIGHT CHAIN PINWHEEL ALKYLPHENYL POLY(OXYPROPYLENE) AMINOCARBAMATES CHEVRON U.S.A. Inc. (US) 1991-04-03 EP disclosed
US-4550111-A BETA-ADRENERGIC BLOCKING AGENTS; DIURETICS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1985-10-29 US disclosed